Bart Cornelissen
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 2%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 34
- Medical Imaging Techniques and Applications 19
- Monoclonal and Polyclonal Antibodies Research 10
- Oncology 37
- PARP inhibition in cancer therapy 10
- HER2/EGFR in Cancer Research 6
- Cancer-related Molecular Pathways 6
- Co-authors
- Veerle Kersemans (49 shared papers)Katherine A. Vallis (23 shared papers)James C. Knight (19 shared papers)Raymond M. Reilly (11 shared papers)Sean Smart (18 shared papers)Kristin McLarty (7 shared papers)Véronique Gouverneur (13 shared papers)Michael Mosley (22 shared papers)
- Journals
- Journal of Nuclear Medicine (19 papers)Nuclear Medicine and Biology (15 papers)European Journal of Nuclear Medicine and Molecular Imaging (11 papers)EJNMMI Research (5 papers)Cancer Biotherapy and Radiopharmaceuticals (3 papers)
- Partner nations
- United KingdomBelgiumNetherlands
In The Last Decade
Bart Cornelissen
109 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 116
- Radiology, Nuclear Medicine and Imaging 953
- Oncology 853
- Pharmaceutical Science 108
- Cancer Research 236
- Structural Biology 19
Countries citing papers authored by Bart Cornelissen
This map shows the geographic impact of Bart Cornelissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Cornelissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Cornelissen more than expected).
Fields of papers citing papers by Bart Cornelissen
This network shows the impact of papers produced by Bart Cornelissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Cornelissen. The network helps show where Bart Cornelissen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Cornelissen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 282 | |
| 2 | 2008 | 103 | |
| 3 | 2010 | 96 | |
| 4 | 2018 | 83 | |
| 5 | 2013 | 69 | |
| 6 | 2012 | 67 | |
| 7 | 2013 | 66 | |
| 8 | 2020 | 59 | |
| 9 | 2009 | 58 | |
| 10 | 2011 | 57 | |
| 11 | 2008 | 50 | |
| 12 | Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy. | 2014 | 48 |
| 13 | 2005 | 47 | |
| 14 | 2012 | 45 | |
| 15 | Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer. | 2014 | 45 |
| 16 | 2020 | 44 | |
| 17 | 2021 | 43 | |
| 18 | 2023 | 40 | |
| 19 | 2019 | 38 | |
| 20 | 2010 | 37 |
About Bart Cornelissen
Bart Cornelissen is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 112 papers that have together received 2.5k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (34 papers), Medical Imaging Techniques and Applications (19 papers), DNA Repair Mechanisms (13 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), PARP inhibition in cancer therapy (10 papers), HER2/EGFR in Cancer Research (6 papers), Radiation Therapy and Dosimetry (6 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (953 citations), Oncology (853 citations), Pharmaceutical Science (108 citations), Cancer Research (236 citations) and Structural Biology (19 citations). Bart Cornelissen has collaborated with scholars based in United Kingdom, Belgium and Netherlands. Frequent co-authors include Veerle Kersemans, Katherine A. Vallis, James C. Knight, Raymond M. Reilly, Sean Smart, Kristin McLarty, Véronique Gouverneur, Michael Mosley, Ruth J. Muschel and Philip D. Allen. Their work appears in journals such as Journal of Nuclear Medicine, Nuclear Medicine and Biology, European Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Research and Cancer Biotherapy and Radiopharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.